Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $66.8100 (-0.74%) ($66.4500 - $67.0400) on Fri. Jan. 11, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2% (three month average) | RSI | 67 | Latest Price | $66.8100(-0.74%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX advances 0.1% a day on average for past five trading days. | Weekly Trend | BAX advances 2.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(57%) SPLV(52%) VYM(51%) XLP(51%) IVE(48%) | Factors Impacting BAX price | BAX will decline at least -1% in a week (0% probabilities). TLT(-19%) DIA(-16%) XHB(-9%) VIXM(-9%) VXX(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1% (StdDev 2%) | Hourly BBV | 0 () | Intraday Trend | -0.1% | | | |
|
5 Day Moving Average | $66.68(0.19%) | 10 Day Moving Average | $66.11(1.06%) | 20 Day Moving Average | $65.22(2.44%) | To recent high | -7.8% | To recent low | 8.7% | Market Cap | $34.085b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |